Activated CaMKII Couples GluN2B and Casein Kinase 2 to Control Synaptic NMDA Receptors  by Sanz-Clemente, Antonio et al.
Cell Reports
ReportActivated CaMKII Couples GluN2B and Casein
Kinase 2 to Control Synaptic NMDA Receptors
Antonio Sanz-Clemente,1 John A. Gray,2 Kyle A. Ogilvie,1 Roger A. Nicoll,2,3 and Katherine W. Roche1,*
1Receptor Biology Section, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health, Bethesda,
MD 20892, USA
2Department of Cellular and Molecular Pharmacology
3Department of Physiology
University of California, San Francisco, CA 94143, USA
*Correspondence: rochek@ninds.nih.gov
http://dx.doi.org/10.1016/j.celrep.2013.02.011SUMMARY
Synaptic activity triggers a profound reorganization
of themolecular composition of excitatory synapses.
For example, NMDA receptors are removed from
synapses in an activity- and calcium-dependent
manner, via casein kinase 2 (CK2) phosphorylation
of the PDZ ligand of the GluN2B subunit (S1480).
However, how synaptic activity drives this process
remains unclear because CK2 is a constitutively
active kinase, which is not directly regulated by
calcium. We show here that activated CaMKII
couples GluN2B and CK2 to form a trimolecular
complex and increases CK2-mediated phosphoryla-
tion of GluN2B S1480. In addition, a GluN2B mutant,
which contains an insert to mimic the GluN2A
sequence and cannot bind to CaMKII, displays re-
duced S1480 phosphorylation and increased surface
expression. We find that although disrupting
GluN2B/CaMKII binding reduces synapse number,
it increases synaptic-GluN2B content. Therefore,
the GluN2B/CaMKII association controls synapse
density and PSD composition in an activity-depen-
dent manner, including recruitment of CK2 for the
removal of GluN2B from synapses.
INTRODUCTION
The molecular composition of the postsynaptic density (PSD) at
excitatory synapses is profoundly modified in response to
synaptic activity, including changes in receptors, scaffolding
proteins, and signaling enzymes (Ehlers, 2003). Glutamate
receptors are important constituents of PSDs, and the dynamic
regulation of their synaptic expression is a central mechanism
for modulating the strength of excitatory neurotransmission.
Therefore, glutamate receptors are subject to strict controlling
mechanisms that allow both short- and long-term modifications
in their number, localization, and composition in a cell- and
synapse-specific manner (Traynelis et al., 2010). N-methyl-D-
aspartate receptors (NMDARs) are ionotropic glutamate re-
ceptors, which, after activation, allow calcium influx into thepostsynaptic spine and trigger a variety of intracellular signaling
cascades (Lau and Zukin, 2007; Sanz-Clemente et al., 2013).
Synaptic NMDARs are dynamically regulated. For example,
there is a switch in the synaptic composition of NMDARs during
development, from GluN2B-containing to GluN2A-containing
receptors (Carmignoto and Vicini, 1992; Quinlan et al., 1999).
Although several molecular mechanisms, including phosphory-
lation and protein-protein interactions, have been identified for
controlling NMDAR subcellular localization and trafficking, our
understanding of synaptic NMDAR regulation remains incom-
plete (Groc et al., 2009; Sanz-Clemente et al., 2013).
We have recently reported that casein kinase 2 (CK2) regulates
subunit composition of synaptic NMDARs by driving the removal
of GluN2B from the synapse. CK2 phosphorylation of the PDZ
ligand of GluN2B (S1480) disrupts the interaction of GluN2B
with scaffolding proteins and allows the lateral diffusion of the
receptor out of the synapse (Chung et al., 2004; Sanz-Clemente
et al., 2010). CK2 is a constitutively active kinase, which is not
directly regulated by calcium (Hathaway and Traugh, 1982;
Olsten and Litchfield, 2004). The CK2-mediated phosphorylation
of GluN2B S1480, however, requires calcium influx through
NMDARs (Chung et al., 2004; Sanz-Clemente et al., 2010).
Thus, it remains unclear how the NMDAR-mediated increase in
postsynaptic calcium regulates NMDARs via phosphorylation
of GluN2B S1480 by CK2.
CaMKII is a major component of the PSD and it is known
that CaMKII translocates to synapses in an activity-dependent
manner to interact with GluN2B-containing NMDARs (Coultrap
and Bayer, 2012; Merrill et al., 2005). We report here an unex-
pected structural role for the activity-dependent association of
GluN2B and CaMKII in regulating synaptic NMDARs by coupling
CK2 to the receptor and facilitating the phosphorylation of
GluN2B within its PDZ ligand. Specifically, we show that CK2
binds to GluN2B upon CaMKII association with the receptor.
Consequently, activated CaMKII promotes the CK2-mediated
phosphorylation of the PDZ ligand of GluN2B (S1480) to control
the synaptic expression of NMDARs.
RESULTS
The phosphorylation of GluN2B by CK2 within its PDZ ligand
(S1480) (Figure 1A) is promoted by NMDAR activity, and the
pharmacological blockade of CaMKII results in the attenuationCell Reports 3, 607–614, March 28, 2013 ª2013 The Authors 607
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Figure 1. Disruption of the CaMKII Binding Site on GluN2B Results in a Decrease in GluN2B S1480 Phosphorylation
(A) Alignment of rat GluN2A and GluN2B subunits, showing the CaMKII binding site (italics boxed) and the YEKL endocytic motif (dotted boxed) on GluN2B. The
PDZ ligand is shown in bold, and residues in red are phosphorylated by the indicated kinases. The two residues (IN) inserted in GluN2B to mimic the GluN2A
sequence are shown underlined in green.
(B) HEK293T cells were transfected with GluN1, PSD-95, and GluN2B (WT or mutants), and the level of GluN2B S1480 phosphorylation was analyzed by
immunoblotting. Graph represents mean ±SEM, n = 4.
(C) Pull-down experiment of GST-GluN2B (WT or 1299IN). Beads were incubated with lysate of HEK293T cells expressing WT CaMKII in the presence of 1 mM
CaCl2 and 3 mM calmodulin (Ca
2+/CaM), and the bound proteins were analyzed with the indicated antibodies.
(D) GluN2B S1480 phosphorylation was analyzed by immunoblotting after transfection into HEK293 cells as explained in (B). Graph represents mean ±SEM.
*p < 0.05 in a Wilcoxon test. n = 5.
(E) In vitro phosphorylation of GluN2B (aa 1120–1482) by CK2. GST-GluN2BWT or 1299IN were incubated with CK2 and ATP for 30 min at 30C. Level of S1480
phosphorylation was analyzed by immunoblotting using a specific phospho-state antibody.
See also Figure S1.of GluN2B S1480 phosphorylation (Chung et al., 2004; Sanz-
Clemente et al., 2010) (Figures S1A and S1B). In addition, it
has been reported that CaMKII directly phosphorylates GluN2B
on S1303 (Omkumar et al., 1996). Therefore, we investigated if
CaMKII-mediated phosphorylation of GluN2B S1303 promotes
CK2 phosphorylation (on S1480), perhaps by inducing a favor-
able conformational change in the GluN2B C-tail. To test this
hypothesis, we generated two GluN2B mutants to either mimic
or block phosphorylation of S1303 (S1303E or S1303A, respec-
tively) and analyzed their level of S1480 phosphorylation by
immunoblotting after transfection into HEK293T cells. We found
that GluN2B S1303E did not enhance S1480 phosphorylation. In
fact, the CK2 phosphorylation appeared to be diminished,
although the effect was not statistically significant (Figure 1B).
This result led us to investigate a second potential mechanism
that might regulate the interplay between CK2 phosphorylation
of GluN2B S1480 and activation of CaMKII: the physical binding
of CaMKII to GluN2B (residues 1290–1309) (Figure 1A) (Bayer
et al., 2001; Strack et al., 2000). Importantly, it has been shown608 Cell Reports 3, 607–614, March 28, 2013 ª2013 The Authorsthat phosphorylation of GluN2B S1303 reduces GluN2B/CaMKII
binding (O’Leary et al., 2011; Strack et al., 2000). Because
GluN2A does not interact with CaMKII in this region (Strack
et al., 2000), we generated a GluN2B mutant in which two resi-
dues (IN) were inserted after R1299 (GluN2B 1299IN), to mimic
the GluN2A sequence in the analogous region (Figure 1A). Using
a pull-down assay, we found that GluN2B 1299IN does not bind
to CaMKII (Figure 1C). We next analyzed the levels of CK2 phos-
phorylation of the PDZ ligand of GluN2B wild-type (WT) or
1299IN. Notably, the phosphorylation of GluN2B 1299IN on
S1480 was dramatically reduced (Figure 1D). However, CK2
phosphorylation of GluN2B 1299IN and WT on S1480 was indis-
tinguishable in an in vitro phosphorylation assay (Figure 1E), sug-
gesting that the direct interaction between GluN2B and CaMKII
promotes S1480 phosphorylation in situ (Figure 1D), but the
mutations per se do not alter CK2 phosphorylation of S1480.
We have recently reported that GluN2B S1480 phos-
phorylation decreases receptor surface expression by dis-
rupting GluN2B binding with MAGUK proteins and inducing
Figure 2. Disruption of the GluN2B/CaMKII
Association Increases the Surface Expres-
sion of GluN2B via S1480 Phosphorylation
(A and B) Hippocampal neurons were trans-
fected at DIV7 with GFP-GluN2BWT or mutants. At
DIV11–12, surface-expressed receptors were
labeled with GFP antibody and Alexa-555-conju-
gated secondary antibody (shown in white). After
permeabilization, the internal pool of receptors was
visualized by anti-GFP and Alexa-633-conjugated
antibody (green). Graph represents means ±SEM.
**p < 0.01, ***p < 0.001 in a one-way ANOVA test; n
(WT, S1303E, S1303A) = 27, 30, 24 (A); n (WT, IN,
E1479Q, IN+E1479Q, S1480E, IN+S1480E) = 23,
29, 22, 19, 20, 28 (B).
Data are from four independent experiments.internalization (Sanz-Clemente et al., 2010). Therefore, we tested
whether the GluN2B/CaMKII association controls GluN2B
surface expression. GFP-tagged GluN2B mutants were ex-
pressed in dissociated hippocampal cultures, and surface-
expressed receptors were visualized by confocal microscopy.
We found that impairing CaMKII binding to GluN2B receptors
with either the S1303E (Figure 2A) or the 1299IN (Figure 2B)
mutations resulted in increased surface expression. In contrast,
GluN2B S1303A was less efficiently expressed on the cell
surface (Figure 2A). To test if the GluN2B/CaMKII association
regulates GluN2B surface expression via S1480 phosphoryla-
tion, we generated GluN2B mutants containing both a disrupted
CaMKII binding site (1299IN) and altered S1480 phosphorylation
(phospho-mimetic: S1480E; and phospho-deficient: E1479Q)
(Sanz-Clemente et al., 2010). Importantly, we found that the
mutations in the PDZ ligand, S1480E or E1479Q, occluded the
effect of GluN2B/CaMKII association in controlling GluN2B
surface expression (Figure 2B), suggesting a commonmolecular
mechanism to control GluN2B surface expression and that
GluN2B/CaMKII binding is an event occurring upstream of CK2
phosphorylation.
Although CK2 is a constitutively active kinase, the phosphory-
lation of its substrates can be regulated by several mechanisms,Cell Reports 3, 607–61includingCK2 localization and targeting to
specific structures via specific protein-
protein interactions (Litchfield, 2003).
Thus, we tested if CaMKII binding to
GluN2B facilitates the association of
CK2 with GluN2B. We first isolated
GluN2B-containing protein complexes
from cultured cortical neurons using a
specific GluN2B antibody and found
that CaMKII coimmunoprecipitated with
GluN2B and, importantly, CK2 was also
found in the same protein complex (Fig-
ure 3A). The AMPA receptor subunit
GluA2,evaluatedasanegativecontrol,did
not coimmunoprecipitate with GluN2B,
indicating the specificity of our assay. To
determine whether the GluN2B/CaMKII
interaction is essential for CK2 binding toGluN2B, we carried out pull-down assays incubating GST-
GluN2B (WT or 1299IN) with cell lysate from HEK293T cells
expressing CaMKII. Because the binding of CaMKII to GluN2B
(residues 1290–1309) is calcium dependent (Bayer et al., 2001),
we performed these experiments in the presence of calcium
and calmodulin (CaM) or EGTA (as a negative control). We found
that bothCaMKII andCK2 associatewithGluN2BWT in the pres-
ence of Ca2+/CaM, but, strikingly, CK2 does not bind to GluN2B
1299IN, which is unable to bind to CaMKII (Figure 3B). Impor-
tantly, neither CaMKII nor CK2 interact with GluN2B in the
presence of EGTA. As expected, both GluN2B WT and 1299IN
bind to PSD-95, evaluated as a control.
Two other GluN2B mutants with impaired binding to CaMKII
have been characterized (Barria and Malinow, 2005; Halt et al.,
2012) (Figure 3C). Therefore, we also tested the CK2 association
to these GluN2B mutants and found that, similar to GluN2B
1299IN, they failed to precipitate CK2 in a pull-down assay
performed in the presence of Ca2+/CaM (Figure 3D).
Our data support the existence of a trimolecular GluN2B/
CaMKII/CK2 complex. To test for direct interaction between
the two kinases, CaMKII and CK2, we performed pull-down ex-
periments, by incubatingGST-CK2with CaMKII (WT or T286D) in
the presence of Ca2+/CaM or EGTA. We observed a robust4, March 28, 2013 ª2013 The Authors 609
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B Figure 3. Activated CaMKII Binds to CK2
and Promotes the Coupling of CK2 to
GluN2B
(A) The P2 fraction from cortical cultures (DIV15)
was isolated, and, after lysis, the association of
CaMKII and CK2 to GluN2B was analyzed by
immunoprecipitation with anti-GluN2B antibody.
(B) Pull-down experiments of GST-GluN2B (WT or
1299IN) performed as in Figure 1C. Beads were
incubated with lysate of HEK293T cells expressing
WT CaMKII (or PSD-95 as a control) in the pres-
ence of 1 mMCaCl2, 3 mM calmodulin (Ca
2+/CaM),
or 1 mM EGTA (EGTA), and the bound proteins
were analyzed with the indicated antibodies.
(C) Sequence of GluN2B and several GluN2B
mutants with impaired CaMKII association (Barria
and Malinow, 2005; Halt et al., 2012). The mutated
residues are shown in red, and the CaMKII binding
site is boxed.
(D) A pull-down assay was performed with
the GluN2B mutants showed in (C) as described in
(B), including Ca2+/CaM. Bound proteins were
analyzed by SDS-PAGE and immunoblotted with
the indicated antibodies.
(E) Pull-down experiments performed as in (B).
GST-CK2 beta was incubated with lysate of
HEK293T expressing WT CaMKII or T286D.
(F) Lysate of HEK293 cells expressing CaMKII
T286D was incubated with anti-CaMKII antibody,
and, after washes, the recovered material was
blotted with the indicated antibodies.interaction between the two kinases when CaMKII is activated
(Figure 3E). Similarly, endogenous CK2 was coimmunoprecipi-
tated from CaMKII-expressing HEK293T cell lysate using a
CaMKII-specific antibody (Figure 3F). Together, these data
show that activated CaMKII interacts with CK2, supporting
a model in which the binding of CaMKII to GluN2B results in
the targeting of CK2 to NMDARs.
To physiologically assess the effects of GluN2B mutations on
the synaptic localization of NMDARs, we analyzed NMDAR-
mediated excitatory postsynaptic currents (EPSCs) in bio-
listically transfected organotypic hippocampal slice cultures.
However, it has been recently reported that the GluN2B/CaMKII
association is critical for maintenance of synapse density
(Gambrill and Barria, 2011). We examined our mutation GluN2B
1299IN, which disrupts binding to CaMKII, and analyzed
synapse number bymeasuring the colocalization of endogenous
pre- and postsynaptic markers (VGlut1 and PSD-95, respec-610 Cell Reports 3, 607–614, March 28, 2013 ª2013 The Authorstively) (Ippolito and Eroglu, 2010). As
shown in Figure 4A, we found that expres-
sion of GluN2B 1299IN in hippocampal
cultured neurons drives a reduction in
the number of synapses compared with
WT GluN2B, consistent with previous
reports (Gambrill and Barria, 2011; Pi
et al., 2010). Therefore, we anticipated
the role of GluN2B/CaMKII binding on
GluN2B trafficking might be obscured
by changes in synapse number whenanalyzing the amplitude of NMDAR currents. However, given
the differential decay properties of the GluN2 subunits (Cull-
Candy and Leszkiewicz, 2004), the analysis of NMDAR kinetics
is a powerful and reliable method to compare the relative contri-
butions of synaptic GluN2A- and GluN2B-containing NMDARs.
Thus, to evaluate the effects of disrupting the GluN2B/CaMKII
association on synaptic NMDAR currents (NMDAR-EPSCs), we
utilized a molecular replacement strategy in hippocampal slice
cultures from GluN2B conditional knockout mice (Grin2bfl/fl).
Slices were biolistically transfected with Cre recombinase and
GluN2B constructs (WT or 1299IN) at days in vitro (DIV)2–DIV4,
and then simultaneous dual whole-cell recordings were obtained
from a transfected neuron and a neighboring nontransfected
control cell at DIV18–24. Transfection of Cre alone reduced the
NMDAR-EPSC by approximately 40%, consistent with our
previous report in acute hippocampal slices (Gray et al., 2011),
and, as expected, the EPSC decay was significantly faster,
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Figure 4. Disrupting the GluN2B-CaMKII Interaction Increases Synaptic Localization of GluN2B-Containing NMDARs
(A) (upper) Cultured hippocampal neurons were transfected with WT GFP-GluN2B or 1299IN at DIV5 and endogenous PSD-95 (red) and VGlut1 (white) labeled at
DIV17. (lower) Synapses were identified by colocalization of PSD-95 and VGlut1 in transfected neurons and quantified. Graph represents mean of colocalized
puncta per 30 mm ± SEM. **p < 0.01 in a Student’s t test; n (WT, 1299IN) = 33, 32. Data are from three independent experiments.
(B and C) Organotypic hippocampal slice cultures were made from P7Grin2bfl/fl mice, biolistically transfected on DIV2–4, and paired whole-cell recordings were
obtained from Cre-expressing and neighboring CA1 pyramidal neurons on DIV18–24. (B) Scatterplots of peak amplitudes of NMDAR-EPSCs from single pairs
(open circles) andmean ± SEM (filled circles) from transfected and control cells (mean amplitude (pA): left, Cre alone, control 138.6 ± 15.0, transfected 79.7 ± 5.7,
n = 8; center, GluN2B WT, control 112.7 ± 12.4, transfected 111.6 ± 13.9, n = 13; right, GluN2B 1299IN control 133.9 ± 13.5, transfected 79.7 ± 11.5, n = 10).
Dashed lines represent linear regression and 95% confidence interval. Sample traces are as follows: control cell, black; transfected cell, green; scale bars
represent 300 ms and 50 pA. (C) Summary graph of NMDAR-EPSC amplitudes. Bars represent the mean ±SEM of the ratios of transfected to control cells from
each pair, expressed as percentages (Cre alone 60.2 ± 4.8, n = 8; GluN2B WT 98.6 ± 4.2, n = 13; GluN2B 1299IN 58.6 ± 5.3, n = 10).
(D) NMDAR-EPSC decay times from cell pairs expressed in ms as a weighted tau (tw) from paired transfected and control cells (mean decay, ms: left, Cre alone,
control 264.5 ± 12.0, transfected 139.5 ± 5.9, n = 8, p < 0.0001; center, GluN2BWT, control 253.0 ± 9.7, transfected 256.5 ± 12.4, n = 13, p = 0.57; right, GluN2B
1299IN, control 251.4 ± 10.5, transfected 315.5 ± 13.3, n = 10, p < 0.0001). Decay kinetics were analyzed by a paired Student’s t test, *p < 0.0001.
(E) Model for the role of GluN2B/CaMKII association in controlling synaptic GluN2B-containing NMDARs. Synaptic activity increases calcium concentration in
spines (via NMDARs) and activates CaMKII. Activated CaMKII associates with both GluN2B and CK2 generating a trimolecular complex GluN2B/CaMKII/CK2.
CK2 phosphorylation on GluN2B S1480 is promoted by the close proximity of the kinase, which disrupts the interaction between GluN2B and MAGUK proteins
and promotes lateral diffusion of GluN2B to extrasynaptic sites.
See also Figure S2.
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suggesting removal of endogenous GluN2B (Figures 4B–4D,
left). Importantly, replacement with WT GluN2B fully and pre-
cisely recovered both the amplitude and decay of the NMDAR-
EPSCs (Figures 4B–4D, center). Consistent with a decrease in
synapse number, GluN2B 1299IN expression did not fully
recover the NMDAR-EPSC amplitude but, importantly, did
significantly slow the decay kinetics (Figures 4B–4D, right). The
slower decay observed with GluN2B 1299IN expression is
consistent with an increased contribution of GluN2B-containing
NMDARs at synapses when the CaMKII interaction is disrupted.
Similar results were obtained with GluN2B 1299IN overexpres-
sion in WT hippocampal slices, though there was less NMDAR-
EPSC amplitude loss, likely due to some retained CaMKII
interaction with endogenous GluN2B subunits (Figure S2A).
To confirm that the slower NMDAR-EPSC decay with GluN2B
1299IN is not due to receptor gating effects, we expressed WT
and mutant GluN2B on a GluN2-null background as previously
described (Chen et al., 2012) We find that the decay kinetics of
a pure population of GluN2B 1299IN-containing NMDARs is
not significantly different from a pure WT GluN2B population
(Figure S2B). Again, the peak amplitude of the NMDAR-EPSC
from the GluN2B 1299IN expressing neurons is significantly
reduced, consistent with a loss of synapses (Figure S2B).
DISCUSSION
In this study, we identify a role for CaMKII in controlling synaptic
NMDAR composition. Specifically, we show that GluN2B
mutants with impaired binding to CaMKII display a reduction in
the CK2-mediated phosphorylation of the GluN2B PDZ ligand,
and a concomitant increase in receptor synaptic expression.
Remarkably, we have identified an association of CK2 and
GluN2B upon CaMKII binding to the receptor. These observa-
tions support a model in which the binding of activated CaMKII
to GluN2B couples CK2 to the receptor and, therefore, facilitates
the phosphorylation of GluN2B S1480 within its PDZ binding
domain (Figure 4E).
CK2 is a ubiquitous serine/threonine kinase, although its
activity in brain, especially in cortex and hippocampus, is higher
than in other nonneuronal tissues (Blanquet, 2000). Typically,
CK2 exists as a tetramer composed of two catalytic subunits
(alpha or alpha prime) and two regulatory subunits (beta). CK2
is considered to be constitutively active. However, a number of
mechanisms regulate CK2 in vivo, including control of CK2
expression level, assembly, and stability and phosphorylation
of either alpha or beta CK2 subunits (Litchfield, 2003). Another
reported mode of modulating phosphorylation by CK2 is the
targeting of the kinase to specific structures. Examples of this
regulatory mechanism are the binding of CK2 to tubulin,
FAF-1, or CKIP-1 (Litchfield, 2003). We have now identified an
unexpected interaction between activated CaMKII and CK2
that supports a role for CaMKII as a scaffolding protein to couple
CK2 to synaptic GluN2B and promote GluN2B removal from
synapses.
CaMKII is a large holoenzyme composed of 12 subunits,
which is activated by calcium influx to the synapse (mainly via
NMDARs) and phosphorylates many synaptic substrates
(including glutamate receptors and MAGUK proteins) (Coultrap612 Cell Reports 3, 607–614, March 28, 2013 ª2013 The Authorsand Bayer, 2012). Catalytic activity of CaMKII plays an important
role at synapses. For example, CaMKII phosphorylation of the
AMPAR subunit GluA1 (on S831) and TARPs regulates hippo-
campal long-term potentiation (LTP) (Lisman et al., 2012). In
addition, a structural role has been proposed for CaMKII
(Coultrap and Bayer, 2012; Griffith et al., 2003; Okamoto et al.,
2009). For example, the physical binding of CaMKII to GluN2B
is involved in synapse maintenance (Figure 4A) (Gambrill and
Barria, 2011), and in the recruiting of the proteasome to dendritic
spines (Bingol et al., 2010).
Remarkably, GluN2B/CaMKII association is also an important
event for memory consolidation. Incubation of acute hippo-
campal slices with a peptide that inhibits this binding is able to
reverse LTP maintenance and decrease synaptic transmission
(Sanhueza et al., 2011). In addition, a knockin mouse ex-
pressing a GluN2B mutant unable to bind to CaMKII (GluN2B
L1298A+R1300Q) displays a reduction in LTP (around 50%)
and shows deficits in the early phases of contextual memory
consolidation (Halt et al., 2012). However, in contrast with our
data and other published reports (Figure 4A) (Gambrill and
Barria, 2011; Pi et al., 2010), no change in synapse density or
in subcellular localization of GluN2B was observed. Similarly,
these knockin mice show normal basal synaptic transmission.
These differences may be the result of the acute versus the
long-term approaches used to disrupt the GluN2B/CaMKII asso-
ciation. In fact, a recent report shows that, in contrast with WT
mice, these knockin animals develop compensatory mecha-
nisms that allow spine outgrowth independent of synaptic
activity (Hamilton et al., 2012). It is also important to note that
each particular mutation used for disrupting GluN2B/CaMKII
binding could potentially produce additional effects that may
explain the subtle differences between the studies.
PSDs are highly dynamic structures, able to rapidly respond to
changes in synaptic activity with dramatic modifications of their
protein content and organization (Ehlers, 2003). However, the
precise mechanisms that drive this remodeling remain unknown.
Our data suggest that CaMKII acts as a central organizer of
excitatory synapses, which works as an activity-dependent
scaffold to regulate synaptic NMDARs. The GluN2 content of
NMDARs defines many functional properties of the receptors,
and GluN2 subunits are differentially regulated. For example,
GluN2A is relatively stable at synapses, whereas GluN2B is
more mobile and undergoes robust lateral diffusion, internaliza-
tion, and recycling (Groc et al., 2006; Lavezzari et al., 2004). In
addition, subunit composition of synaptic NMDARs is develop-
mentally regulated and changes from predominantly GluN2B-
containing to GluN2A-containing during synaptic maturation.
We have recently shown that CK2 activity plays a role in this
process and that GluN2B S1480 phosphorylation peaks during
the critical period for the switch (Sanz-Clemente et al., 2010).
The precise role of CaMKII in the NMDAR subunit shift is less
clear. For example, incubation of hippocampal slices with the
CaMKII inhibitor KN93 does not prevent the LTP-induced
NMDAR subunit switch (Matta et al., 2011). However, only
a modest percentage (around 40%) of CaMKII is inhibited by
10 mM KN62 (a KN93-analogous drug), in hippocampal slices
(Lee et al., 2009). In addition, the pharmacological inhibition
of synaptic activity, NMDAR activity or CaMKII activity (using
TTX, APV, or KN93, respectively) does not block GluN2B S1480
phosphorylation, but reduces it by around 50% (Chung et al.,
2004; Sanz-Clemente et al., 2010). Data, therefore, are con-
sistent with the constitutively active nature of CK2 and with our
model in which GluN2B S1480 phosphorylation is ‘‘facilitated’’
by CaMKII/GluN2B interaction.
In this study, we have identified an unexpected modulator for
GluN2B synaptic expression: the physical association between
GluN2B and CaMKII. Our data are consistent with a model
in which NMDAR-mediated activation of CaMKII leads to
the formation of a trimolecular GluN2B/CaMKII/CK2 complex.
Therefore, CK2 phosphorylation within the GluN2B PDZ ligand
(S1480) is facilitated by the close proximity of the substrate (Fig-
ure 4E). Phosphorylation on S1480 results in the disruption of the
association of GluN2B with MAGUK proteins and the decrease
of the phosphorylation of GluN2B on Y1472, within a neighboring
endocytic motif (YEKL). GluN2B-containing receptors diffuse to
extrasynaptic sites via a non-PDZ interaction with SAP102 (Chen
et al., 2012), where they ultimately will be internalized via
the association of the clathrin adaptor complex AP-2 with the
GluN2B YEKL motif (Prybylowski et al., 2005; Sanz-Clemente
et al., 2010). Therefore, phosphorylation on the PDZ ligand of
GluN2B results in a dramatic decrease of synaptic GluN2B
expression (Chen et al., 2012). This mechanism controls the
clearance of GluN2B from synapses, but does not affect GluN2A
subunits, because CaMKII cannot bind to GluN2A (Strack et al.,
2000). In addition, the PDZ ligand of GluN2A is not a good
substrate for CK2 phosphorylation (Sanz-Clemente et al.,
2010). Recent studies support the existence of a significant
amount of NMDARs assembled as triheteromers (GluN1/
GluN2A/GluN2B) in forebrain (Al-Hallaq et al., 2007; Gray et al.,
2011; Rauner and Ko¨hr, 2011). Therefore, triheteromers would
be a critical population of synaptic NMDARs at highly plastic
synapses (such as CA1 hippocampal neurons) because the
presence of GluN2A likely promotes the stable expression of
NMDARs at synaptic sites, even if CaMKII is associated with
the receptor complex (via the GluN2B subunit). In summary,
our data reveal a critical structural role for CaMKII acting as
a scaffolding protein to modulate the activity-dependent regula-
tion of synaptic NMDARs.EXPERIMENTAL PROCEDURES
The use and care of animals used in this study followed the guidelines of the
UCSF and NIH Animal Research Advisory Committees. For pull-down and
coimmunoprecipitation experiments, samples were lysed in buffer containing
1% Triton X-100 or 1% Triton X-100; 0.5% sodium deoxycholate (DOC); 0.1%
SDS in the presence of 1 mMCaCl2; and 3 mMcalmodulin (Ca
2+/CaM) or 1 mM
EGTA (EGTA) and incubated with the appropriate antibody and protein A/G
beads or indicated GST-fusion proteins at 4C. After washes, beads were
analyzed by SDS-PAGE and immunoblotting. Immunofluorescence was per-
formed as previously reported (Sanz-Clemente et al., 2010). GFP-tagged
GluN2B was transfected into hippocampal neurons at DIV7, and surface
expression was analyzed at DIV11–12. The number of synapses was quanti-
fied by labeling endogenous PSD-95 and VGlut1 at DIV17 after transfection
of pCAG-GluN2B-IRES-GFP at DIV5. For electrophysiological recordings,
hippocampi were dissected from P7 Grin2bfl/fl mice and biolistically
transfected after 2–4 days in culture with pFUGW-Cre:mCherry and either
pCAG-GFP or pCAG-GluN2B-IRES-GFP or mutants. Slices were cultured
for an additional 14–20 days and dual whole-cell patch-clamp recordingswere performed from neighboring CA1 pyramidal cells. NMDAR-EPSCs
were recorded at +40 mV in the presence of 10 mM NBQX. Additional details
are available in Extended Experimental Procedures.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures
and two figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2013.02.011.LICENSING INFORMATION
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